Primary Site >> Biliary tract Cancer
Gene >> BRAF
| 1. | |||||||||||
| Journal: | Hepatology. 2002 Jun;35(6):1329-40. | ||||||||||
| Title: | Stimulation of alpha2-adrenergic receptor inhibits cholangiocarcinoma growth through modulation of Raf-1 and B-Raf activities. | ||||||||||
| Author: | Kanno, Noriatsu|Lesage, Gene|Phinizy, Jo Lynne|Glaser, Shannon|Francis, Heather|Alpini, Gianfranco | ||||||||||
| PMID: | 12029618 | ||||||||||
| 2. | |||||||||||
| Journal: | Gut. 2003 May;52(5):706-12. | ||||||||||
| Title: | Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma. | ||||||||||
| Author: | Tannapfel, A|Sommerer, F|Benicke, M|Katalinic, A|Uhlmann, D|Witzigmann, H|Hauss, J|Wittekind, C | ||||||||||
| PMID: | 12692057 | ||||||||||
| 3. | |||||||||||
| Journal: | Am J Physiol Gastrointest Liver Physiol. 2004 Jun;286(6):G973-82. | ||||||||||
| Title: | Tauroursodeoxycholate inhibits human cholangiocarcinoma growth via Ca2+-, PKC-, and MAPK-dependent pathways. | ||||||||||
| Author: | Alpini, Gianfranco|Kanno, Noriatsu|Phinizy, Jo Lynne|Glaser, Shannon|Francis, Heather|Taffetani, Silvia|LeSage, Gene | ||||||||||
| PMID: | 14701718 | ||||||||||
| 4. | |||||||||||
| Journal: | Mod Pathol. 2004 Nov;17(11):1386-91. | ||||||||||
| Title: | The V599E BRAF mutation is uncommon in biliary tract cancers. | ||||||||||
| Author: | Goldenberg, David|Rosenbaum, Eli|Argani, Pedram|Wistuba, Ignacio I|Sidransky, David|Thuluvath, Paul J|Hidalgo, Manuel|Califano, Joseph|Maitra, Anirban | ||||||||||
| PMID: | 15181454 | ||||||||||
| 5. | |||||||||||
| Journal: | Virchows Arch. 2004 Aug;445(2):179-82. Epub 2004 Jun 19. | ||||||||||
| Title: | Mutational analysis of BRAF in gallbladder carcinomas in association with K-ras and p53 mutations and microsatellite instability. | ||||||||||
| Author: | Saetta, Angelica A|Papanastasiou, Pollyanthi|Michalopoulos, Nikolaos V|Gigelou, Fanie|Korkolopoulou, Penelope|Bei, Thaleia|Patsouris, Efstratios | ||||||||||
| PMID: | 15221372 | ||||||||||
| 6. | |||||||||||
| Journal: | Tumour Biol. 2007;28(5):290-300. Epub 2007 Oct 26. | ||||||||||
| Title: | Molecular testing for microsatellite instability and DNA mismatch repair defects in hereditary and sporadic colorectal cancers--ready for prime time? | ||||||||||
| Author: | Soreide, Kjetil | ||||||||||
| PMID: | 17962726 | ||||||||||
| 7. | |||||||||||
| Journal: | J Gastrointest Surg. 2009 Aug;13(8):1510-6. | ||||||||||
| Title: | Molecular analysis of PIK3CA, BRAF, and RAS oncogenes in periampullary and ampullary adenomas and carcinomas. | ||||||||||
| Author: | Schonleben, Frank|Qiu, Wanglong|Allendorf, John D|Chabot, John A|Remotti, Helen E|Su, Gloria H | ||||||||||
| PMID: | 19440799 | ||||||||||
| 8. | |||||||||||
| Journal: | Br J Cancer. 2010 Jan 5;102(1):68-72. | ||||||||||
| Title: | Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial. | ||||||||||
| Author: | Bengala, C|Bertolini, F|Malavasi, N|Boni, C|Aitini, E|Dealis, C|Zironi, S|Depenni, R|Fontana, A|Del Giovane, C|Luppi, G|Conte, P | ||||||||||
| PMID: | 19935794 | ||||||||||
| 9. | |||||||||||
| Journal: | Biomed Pharmacother. 2011 Feb;65(1):22-6. | ||||||||||
| Title: | KRAS and PIK3CA but not BRAF genes are frequently mutated in Chinese cholangiocarcinoma patients. | ||||||||||
| Author: | Xu, Rui Feng|Sun, Ji Ping|Zhang, Shi Rong|Zhu, Guan Shan|Li, Li Bo|Liao, Yu Lin|Xie, Jian Ming|Liao, Wang Jun | ||||||||||
| PMID: | 21051183 | ||||||||||
| 10. | |||||||||||
| Journal: | Appl Immunohistochem Mol Morphol. 2011 Mar;19(2):133-40. | ||||||||||
| Title: | Mutations in the RAS/RAF/MAP kinase pathway commonly occur in gallbladder adenomas but are uncommon in gallbladder adenocarcinomas. | ||||||||||
| Author: | Pai, Rish K|Mojtahed, Kaveh|Pai, Reetesh K | ||||||||||
| PMID: | 21307665 | ||||||||||
| 11. | |||||||||||
| Journal: | Hum Pathol. 2012 Mar;43(3):440-5. | ||||||||||
| Title: | Intraductal tubulopapillary neoplasm of the bile duct: potential origin from peribiliary cysts. | ||||||||||
| Author: | Zen, Yoh|Amarapurkar, Anjali D|Portmann, Bernard C | ||||||||||
| PMID: | 21813159 | ||||||||||
| 12. | |||||||||||
| Journal: | Gastroenterology. 2012 Apr;142(4):1021-1031.e15. | ||||||||||
| Title: | Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors. | ||||||||||
| Author: | Andersen, Jesper B|Spee, Bart|Blechacz, Boris R|Avital, Itzhak|Komuta, Mina|Barbour, Andrew|Conner, Elizabeth A|Gillen, Matthew C|Roskams, Tania|Roberts, Lewis R|Factor, Valentina M|Thorgeirsson, Snorri S | ||||||||||
| PMID: | 22178589 | ||||||||||
| 13. | |||||||||||
| Journal: | Oncologist. 2012;17(1):72-9. | ||||||||||
| Title: | Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. | ||||||||||
| Author: | Borger, Darrell R|Tanabe, Kenneth K|Fan, Kenneth C|Lopez, Hector U|Fantin, Valeria R|Straley, Kimberly S|Schenkein, David P|Hezel, Aram F|Ancukiewicz, Marek|Liebman, Hannah M|Kwak, Eunice L|Clark, Jeffrey W|Ryan, David P|Deshpande, Vikram|Dias-Santagata, | ||||||||||
| PMID: | 22180306 | ||||||||||
| 14. | |||||||||||
| Journal: | Hum Pathol. 2013 Jul;44(7):1216-22. | ||||||||||
| Title: | Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions. | ||||||||||
| Author: | Voss, Jesse S|Holtegaard, Leonard M|Kerr, Sarah E|Fritcher, Emily G Barr|Roberts, Lewis R|Gores, Gregory J|Zhang, Jun|Highsmith, W Edward|Halling, Kevin C|Kipp, Benjamin R | ||||||||||
| PMID: | 23391413 | ||||||||||
| 15. | |||||||||||
| Journal: | Ann Oncol. 2013 Dec;24(12):3061-5. | ||||||||||
| Title: | A phase II trial of gemcitabine, irinotecan and panitumumab in advanced cholangiocarcinoma. | ||||||||||
| Author: | Sohal, D P S|Mykulowycz, K|Uehara, T|Teitelbaum, U R|Damjanov, N|Giantonio, B J|Carberry, M|Wissel, P|Jacobs-Small, M|O'Dwyer, P J|Sepulveda, A|Sun, W | ||||||||||
| PMID: | 24146220 | ||||||||||
| 16. | |||||||||||
| Journal: | Hum Pathol. 2013 Dec;44(12):2768-73. | ||||||||||
| Title: | The frequency of KRAS and BRAF mutations in intrahepatic cholangiocarcinomas and their correlation with clinical outcome. | ||||||||||
| Author: | Robertson, Scott|Hyder, Omar|Dodson, Rebecca|Nayar, Suresh K|Poling, Justin|Beierl, Katie|Eshleman, James R|Lin, Ming-Tseh|Pawlik, Timothy M|Anders, Robert A | ||||||||||
| PMID: | 24139215 | ||||||||||
| 17. | |||||||||||
| Journal: | Gastroenterology. 2013 Apr;144(4):829-40. | ||||||||||
| Title: | Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. | ||||||||||
| Author: | Sia, Daniela|Hoshida, Yujin|Villanueva, Augusto|Roayaie, Sasan|Ferrer, Joana|Tabak, Barbara|Peix, Judit|Sole, Manel|Tovar, Victoria|Alsinet, Clara|Cornella, Helena|Klotzle, Brandy|Fan, Jian-Bing|Cotsoglou, Christian|Thung, Swan N|Fuster, Josep|Waxman, Sam | ||||||||||
| PMID: | 23295441 | ||||||||||
| 18. | |||||||||||
| Journal: | Hepatology. 2014 Apr;59(4):1427-34. | ||||||||||
| Title: | Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma. | ||||||||||
| Author: | Arai, Yasuhito|Totoki, Yasushi|Hosoda, Fumie|Shirota, Tomoki|Hama, Natsuko|Nakamura, Hiromi|Ojima, Hidenori|Furuta, Koh|Shimada, Kazuaki|Okusaka, Takuji|Kosuge, Tomoo|Shibata, Tatsuhiro | ||||||||||
| PMID: | 24122810 | ||||||||||
| 19. | |||||||||||
| Journal: | Mod Pathol. 2014 May;27(5):731-9. | ||||||||||
| Title: | High throughput molecular profiling reveals differential mutation patterns in intrahepatic cholangiocarcinomas arising in chronic advanced liver diseases. | ||||||||||
| Author: | Jang, Sejin|Chun, Sung-Min|Hong, Seoung-Mo|Sung, Chang Ohk|Park, Hosub|Kang, Hyo Jeong|Kim, Kyu-pyo|Lee, Young Joo|Yu, Eunsil | ||||||||||
| PMID: | 24186137 | ||||||||||
| 20. | |||||||||||
| Journal: | Mod Pathol. 2014 May;27(5):665-74. | ||||||||||
| Title: | Epidermal growth factor receptor signaling pathway is frequently altered in ampullary carcinoma at protein and genetic levels. | ||||||||||
| Author: | Mikhitarian, Kaidi|Pollen, Maressa|Zhao, Zhiguo|Shyr, Yu|Merchant, Nipun B|Parikh, Alexander|Revetta, Frank|Washington, M Kay|Vnencak-Jones, Cindy|Shi, Chanjuan | ||||||||||
| PMID: | 24186143 | ||||||||||
| 21. | |||||||||||
| Journal: | Mod Pathol. 2014 Jul;27(7):1028-34. | ||||||||||
| Title: | BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinoma. | ||||||||||
| Author: | Goeppert, Benjamin|Frauenschuh, Lena|Renner, Marcus|Roessler, Stephanie|Stenzinger, Albrecht|Klauschen, Frederick|Warth, Arne|Vogel, Monika Nadja|Mehrabi, Arianeb|Hafezi, Mohammadreza|Boehmer, Katja|von Deimling, Andreas|Schirmacher, Peter|Weichert, Wilko | ||||||||||
| PMID: | 24309328 | ||||||||||
| 22. | |||||||||||
| Journal: | J Gastroenterol Hepatol. 2014 May;29(5):1119-25. | ||||||||||
| Title: | Clinicopathological and prognostic significances of EGFR, KRAS and BRAF mutations in biliary tract carcinomas in Taiwan. | ||||||||||
| Author: | Chang, Yu-Ting|Chang, Ming-Chu|Huang, Kai-Wen|Tung, Chien-Chih|Hsu, Chiun|Wong, Jau-Min | ||||||||||
| PMID: | 24372748 | ||||||||||
| 23. | |||||||||||
| Journal: | Ann Surg Oncol. 2014 Nov;21(12):3827-34. | ||||||||||
| Title: | Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets. | ||||||||||
| Author: | Zhu, Andrew X|Borger, Darrell R|Kim, Yuhree|Cosgrove, David|Ejaz, Aslam|Alexandrescu, Sorin|Groeschl, Ryan Thomas|Deshpande, Vikram|Lindberg, James M|Ferrone, Cristina|Sempoux, Christine|Yau, Thomas|Poon, Ronnie|Popescu, Irinel|Bauer, Todd W|Gamblin, T Cl | ||||||||||
| PMID: | 24889489 | ||||||||||
| 24. | |||||||||||
| Journal: | Ecancermedicalscience. 2014 Nov 6;8:479. | ||||||||||
| Title: | Dramatic response to dabrafenib and trametinib combination in a BRAF V600E-mutated cholangiocarcinoma: implementation of a molecular tumour board and next-generation sequencing for personalized medicine. | ||||||||||
| Author: | Loaiza-Bonilla, Arturo|Clayton, Erica|Furth, Emma|O'Hara, Mark|Morrissette, Jennifer | ||||||||||
| PMID: | 25435907 | ||||||||||
| 25. | |||||||||||
| Journal: | PLoS One. 2014 Dec 23;9(12):e115383. | ||||||||||
| Title: | Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications. | ||||||||||
| Author: | Churi, Chaitanya R|Shroff, Rachna|Wang, Ying|Rashid, Asif|Kang, HyunSeon C|Weatherly, Jacqueline|Zuo, Mingxin|Zinner, Ralph|Hong, David|Meric-Bernstam, Funda|Janku, Filip|Crane, Christopher H|Mishra, Lopa|Vauthey, Jean-Nicholas|Wolff, Robert A|Mills, Gord | ||||||||||
| PMID: | 25536104 | ||||||||||
| 26. | |||||||||||
| Journal: | Histopathology. 2015 Oct;67(4):562-7. | ||||||||||
| Title: | BRAF V600E mutational status in bile duct adenomas and hamartomas. | ||||||||||
| Author: | Pujals, Anais|Bioulac-Sage, Paulette|Castain, Claire|Charpy, Cecile|Zafrani, Elie Serge|Calderaro, Julien | ||||||||||
| PMID: | 25704541 | ||||||||||
| 27. | |||||||||||
| Journal: | Exp Mol Pathol. 2015 Oct;99(2):240-4. | ||||||||||
| Title: | Molecular profiling of intrahepatic and extrahepatic cholangiocarcinoma using next generation sequencing. | ||||||||||
| Author: | Putra, Juan|de Abreu, Francine B|Peterson, Jason D|Pipas, J Marc|Mody, Kabir|Amos, Christopher I|Tsongalis, Gregory J|Suriawinata, Arief A | ||||||||||
| PMID: | 26189129 | ||||||||||
| 28. | |||||||||||
| Journal: | Mod Pathol. 2015 Sep;28(9):1249-64. | ||||||||||
| Title: | Intraductal tubulopapillary neoplasms of the bile ducts: clinicopathologic, immunohistochemical, and molecular analysis of 20 cases. | ||||||||||
| Author: | Schlitter, Anna Melissa|Jang, Kee-Taek|Kloppel, Gunter|Saka, Burcu|Hong, Seung-Mo|Choi, Hyejeong|Offerhaus, George Johan|Hruban, Ralph H|Zen, Yoh|Konukiewitz, Bjorn|Regel, Ivonne|Allgauer, Michael|Balci, Serdar|Basturk, Olca|Reid, Michelle D|Esposito, Ire | ||||||||||
| PMID: | 26111977 | ||||||||||
| 29. | |||||||||||
| Journal: | Nat Commun. 2015 Jan 22;6:6087. | ||||||||||
| Title: | Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma. | ||||||||||
| Author: | Sia, Daniela|Losic, Bojan|Moeini, Agrin|Cabellos, Laia|Hao, Ke|Revill, Kate|Bonal, Dennis|Miltiadous, Oriana|Zhang, Zhongyang|Hoshida, Yujin|Cornella, Helena|Castillo-Martin, Mireia|Pinyol, Roser|Kasai, Yumi|Roayaie, Sasan|Thung, Swan N|Fuster, Josep|Schw | ||||||||||
| PMID: | 25608663 | ||||||||||
| 30. | |||||||||||
| Journal: | Best Pract Res Clin Gastroenterol. 2015 Apr;29(2):233-44. | ||||||||||
| Title: | Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways. | ||||||||||
| Author: | Kongpetch, Sarinya|Jusakul, Apinya|Ong, Choon Kiat|Lim, Weng Khong|Rozen, Steven G|Tan, Patrick|Teh, Bin Tean | ||||||||||
| PMID: | 25966424 | ||||||||||
| 31. | |||||||||||
| Journal: | Clin Cancer Res. 2016 Jan 15;22(2):291-300. | ||||||||||
| Title: | Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma. | ||||||||||
| Author: | Moeini, Agrin|Sia, Daniela|Bardeesy, Nabeel|Mazzaferro, Vincenzo|Llovet, Josep M | ||||||||||
| PMID: | 26405193 | ||||||||||
| 32. | |||||||||||
| Journal: | Hepatol Res. 2016 Jun;46(7):713-8. | ||||||||||
| Title: | Intraductal tubulopapillary neoplasm of the bile duct: A case report and review of the published work. | ||||||||||
| Author: | Nakagawa, Takashi|Arisaka, Yoshifumi|Ajiki, Tetsuo|Fujikura, Kohei|Masuda, Atsuhiro|Takenaka, Mamoru|Shiomi, Hideyuki|Okabe, Yoshihiro|Fukumoto, Takumi|Ku, Yonson|Azuma, Takeshi|Zen, Yoh | ||||||||||
| PMID: | 26459784 | ||||||||||
| 33. | |||||||||||
| Journal: | J Clin Pathol. 2016 May;69(5):403-8. | ||||||||||
| Title: | Comprehensive genomic profiling of extrahepatic cholangiocarcinoma reveals a long tail of therapeutic targets. | ||||||||||
| Author: | Lee, Hwajeong|Wang, Kai|Johnson, Adrienne|Jones, David M|Ali, Siraj M|Elvin, Julia A|Yelensky, Roman|Lipson, Doron|Miller, Vincent A|Stephens, Philip J|Javle, Milind|Ross, Jeffrey S | ||||||||||
| PMID: | 26500333 | ||||||||||
| 34. | |||||||||||
| Journal: | Mod Pathol. 2016 Mar;29(3):293-301. | ||||||||||
| Title: | Cholangiocarcinoma with intraductal tubular growth pattern versus intraductal papillary growth pattern. | ||||||||||
| Author: | Tsukahara, Tetsuo|Shimoyama, Yoshie|Ebata, Tomoki|Yokoyama, Yukihiro|Igami, Tsuyoshi|Sugawara, Gen|Mizuno, Takashi|Yamaguchi, Junpei|Nakamura, Shigeo|Nagino, Masato | ||||||||||
| PMID: | 26769137 | ||||||||||
| 35. | |||||||||||
| Journal: | Cancer Metastasis Rev. 2016 Jun;35(2):263-75. | ||||||||||
| Title: | Genomics of gallbladder cancer: the case for biomarker-driven clinical trial design. | ||||||||||
| Author: | Sicklick, Jason K|Fanta, Paul T|Shimabukuro, Kelly|Kurzrock, Razelle | ||||||||||
| PMID: | 26857926 | ||||||||||
| 36. | |||||||||||
| Journal: | Oncotarget. 2016 Jul 19;7(29):46750-46767. | ||||||||||
| Title: | The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets. | ||||||||||
| Author: | Chong, Dawn Q|Zhu, Andrew X | ||||||||||
| PMID: | 27102149 | ||||||||||
| 37. | |||||||||||
| Journal: | J Gastrointest Oncol. 2016 Oct;7(5):797-803. | ||||||||||
| Title: | Molecular profiling of biliary tract cancer: a target rich disease. | ||||||||||
| Author: | Jain, Apurva|Javle, Milind | ||||||||||
| PMID: | 27747093 | ||||||||||
| 38. | |||||||||||
| Journal: | Crit Rev Oncol Hematol. 2016 Nov;107:111-118. | ||||||||||
| Title: | Molecular characteristics of biliary tract cancer. | ||||||||||
| Author: | Sohal, Davendra P S|Shrotriya, Shiva|Abazeed, Mohamed|Cruise, Michael|Khorana, Alok | ||||||||||
| PMID: | 27823638 | ||||||||||
| 39. | |||||||||||
| Journal: | Jpn Clin Med. 2016 Dec 13;7:33-39. | ||||||||||
| Title: | KRAS Mutation as a Potential Prognostic Biomarker of Biliary Tract Cancers. | ||||||||||
| Author: | Yokoyama, Masaaki|Ohnishi, Hiroaki|Ohtsuka, Kouki|Matsushima, Satsuki|Ohkura, Yasuo|Furuse, Junji|Watanabe, Takashi|Mori, Toshiyuki|Sugiyama, Masanori | ||||||||||
| PMID: | 28008299 | ||||||||||
| 40. | |||||||||||
| Journal: | J Gastrointest Oncol. 2016 Dec;7(6):E98-E102. | ||||||||||
| Title: | Impressive response to dual BRAF and MEK inhibition in patients with BRAF mutant intrahepatic cholangiocarcinoma-2 case reports and a brief review. | ||||||||||
| Author: | Lavingia, Viraj|Fakih, Marwan | ||||||||||
| PMID: | 28078132 | ||||||||||
| 41. | |||||||||||
| Journal: | Histopathology. 2017 Feb;70(3):485-491. | ||||||||||
| Title: | BRAF V600E mutation in biliary proliferations associated with alpha1 -antitrypsin deficiency. | ||||||||||
| Author: | Angkathunyakul, Napat|Rosini, Francesca|Heaton, Nigel|Foskett, Pierre|Quaglia, Alberto | ||||||||||
| PMID: | 27627051 | ||||||||||
| 42. | |||||||||||
| Journal: | Cancer Control. 2017 Jul-Sep;24(3):1073274817729241. | ||||||||||
| Title: | Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma. | ||||||||||
| Author: | Chun, Yun Shin|Javle, Milind | ||||||||||
| PMID: | 28975832 | ||||||||||
| 43. | |||||||||||
| Journal: | Pathol Res Pract. 2017 Aug;213(8):1010-1013. | ||||||||||
| Title: | Adenosquamous gallbladder carcinoma: Multigene hotspot mutational profiling reveals a monoclonal origin of the two components. | ||||||||||
| Author: | Galuppini, Francesca|Salmaso, Roberta|Valentini, Elisa|Lanza, Cristiano|Maretto, Isacco|Nitti, Donato|Rugge, Massimo|Fassan, Matteo | ||||||||||
| PMID: | 28698100 | ||||||||||
| 44. | |||||||||||
| Journal: | J Gastrointest Oncol. 2017 Apr;8(2):E32-E38. | ||||||||||
| Title: | Combined dabrafenib and trametinib treatment in a case of chemotherapy-refractory extrahepatic BRAF V600E mutant cholangiocarcinoma: dramatic clinical and radiological response with a confusing synchronic new liver lesion. | ||||||||||
| Author: | Kocsis, Judit|Arokszallasi, Anita|Andras, Csilla|Balogh, Ingrid|Beres, Edit|Deri, Julia|Petak, Istvan|Janvary, Levente|Horvath, Zsolt | ||||||||||
| PMID: | 28480077 | ||||||||||
| 45. | |||||||||||
| Journal: | Onco Targets Ther. 2017 Feb 17;10:965-971. | ||||||||||
| Title: | BRAF(V600) mutations in solid tumors, other than metastatic melanoma and papillary thyroid cancer, or multiple myeloma: a screening study. | ||||||||||
| Author: | Cohn, Allen L|Day, Bann-Mo|Abhyankar, Sarang|McKenna, Edward|Riehl, Todd|Puzanov, Igor | ||||||||||
| PMID: | 28255242 | ||||||||||
| 46. | |||||||||||
| Journal: | J Formos Med Assoc. 2017 Jun;116(6):464-468. | ||||||||||
| Title: | Mutation analysis and copy number changes of KRAS and BRAF genes in Taiwanese cases of biliary tract cholangiocarcinoma. | ||||||||||
| Author: | Huang, Wen-Chih|Tsai, Chien-Chen|Chan, Chih-Chieh | ||||||||||
| PMID: | 27745798 | ||||||||||
| 47. | |||||||||||
| Journal: | Br J Cancer. 2018 Feb 20;118(4):462-470. | ||||||||||
| Title: | Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer. | ||||||||||
| Author: | Kim, R D|Alberts, S R|Pena, C|Genvresse, I|Ajavon-Hartmann, A|Xia, C|Kelly, A|Grilley-Olson, J E | ||||||||||
| PMID: | 29348486 | ||||||||||
| 48. | |||||||||||
| Journal: | Future Oncol. 2018 Mar;14(6):553-566. | ||||||||||
| Title: | Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma. | ||||||||||
| Author: | DeLeon, Thomas T|Ahn, Daniel H|Bogenberger, James M|Anastasiadis, Panos Z|Arora, Mansi|Ramanathan, Ramesh K|Aqel, Bashar A|Vasmatzis, George|Truty, Mark J|Oklu, Rahmi|Bekaii-Saab, Tanios S|Borad, Mitesh J | ||||||||||
| PMID: | 29460642 | ||||||||||
| 49. | |||||||||||
| Journal: | Oncologist. 2018 Sep;23(9):998-1003. | ||||||||||
| Title: | Hybrid Capture-Based Tumor Sequencing and Copy Number Analysis to Confirm Origin of Metachronous Metastases in BRCA1-Mutant Cholangiocarcinoma Harboring a Novel YWHAZ-BRAF Fusion. | ||||||||||
| Author: | Lim, Huat C|Montesion, Meagan|Botton, Thomas|Collisson, Eric A|Umetsu, Sarah E|Behr, Spencer C|Gordan, John D|Stephens, Phil J|Kelley, Robin K | ||||||||||
| PMID: | 29622700 | ||||||||||
| 50. | |||||||||||
| Journal: | Z Gastroenterol. 2018 Apr;56(4):384-397. | ||||||||||
| Title: | [ASCO- and ESMO-update 2017 - highlights of the 53. meeting of the American Society of Clinical Oncology/ASCO 2017 and European Society for Medical Oncology/ESMO congress 2017]. | ||||||||||
| Author: | Ettrich, Thomas J|Ebert, Matthias|Lorenzen, Sylvie|Moehler, Markus|Vogel, Arndt|Witkowski, Lukas|Seufferlein, Thomas|Reinacher-Schick, Anke | ||||||||||
| PMID: | 29642252 | ||||||||||
| 51. | |||||||||||
| Journal: | Hum Pathol. 2018 Aug;78:131-137. | ||||||||||
| Title: | Mucinous intrahepatic cholangiocarcinoma: a distinct variant. | ||||||||||
| Author: | Chi, Zhikai|Bhalla, Amarpreet|Saeed, Omer|Cheng, Liang|Curless, Kendra|Wang, Hanlin L|Patil, Deepa T|Lin, Jingmei | ||||||||||
| PMID: | 29698701 | ||||||||||
| 52. | |||||||||||
| Journal: | Invest New Drugs. 2018 May 22. pii: 10.1007/s10637-018-0600-2. | ||||||||||
| Title: | Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer. | ||||||||||
| Author: | Finn, R S|Ahn, D H|Javle, M M|Tan, B R Jr|Weekes, C D|Bendell, J C|Patnaik, A|Khan, G N|Laheru, D|Chavira, R|Christy-Bittel, J|Barrett, E|Sawyer, M B|Bekaii-Saab, Tanios S | ||||||||||
| PMID: | 29785570 | ||||||||||
| 53. | |||||||||||
| Journal: | Jpn J Clin Oncol. 2018 Aug 1;48(8):703-711. | ||||||||||
| Title: | New developments in systemic therapy for advanced biliary tract cancer. | ||||||||||
| Author: | Morizane, Chigusa|Ueno, Makoto|Ikeda, Masafumi|Okusaka, Takuji|Ishii, Hiroshi|Furuse, Junji | ||||||||||
| PMID: | 29893894 | ||||||||||